Anti-Infective Antibodies Market to Witness Widespread Expansion by 2020

Anti-infective antibodies are being used extensively nowadays to treat serious bacterial and viral diseases such as pneumonia, tuberculosis and malaria. According to the World Health Organization, six major infectious diseases namely diarrhea, pneumonia, malaria, acquired immune deficiency syndrome (AIDS), measles and tuberculosis are responsible for half of the premature deaths worldwide killing children and young adults. Moreover, threatening pandemics such as H1N1 influenza A virus (swine flu) is also adding pressure on healthcare sector. On the basis of these diseases which are being treated with the help of anti-infective antibodies, Anti-Infective Antibodies Market is divided into four major segments namely recombinant antibodies for viral diseases, recombinant antibodies for bacterial diseases, human plasma-derived immunoglobulins and Varicella Zoster immunoglobulins (VZIG).

Among the mentioned anti-infective antibodies, the major market share is captured by recombinant antibodies for viral diseases followed by recombinant antibodies for bacterial diseases due to high prevalence of these diseases worldwide. According to the World Health Organization reports, 13.3 million people were suffering from AIDS in 2013 all over the world. Among the different antibodies available, the major anti-infective antibodies which are revolutionizing the market include truvada and valtrex, which are anti-HIV and anti-herpes antibodies respectively.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3575

Additionally, the growing emergence of antibody resistant microorganisms, lethal virus and threat from engineered microorganisms is stimulating the interest of researchers towards developing novel anti-infective antibodies. Advances in understanding the mechanisms and new anti-bodies technologies are also contributing for the growing class of anti-infective antibodies in research and development. In anti-infective antibodies market, large numbers of companies are undergoing clinical trials as for instance, Novaratis AG is performing Phase IIb clinical trials of Albuferon, drug for the treatment of hepatitis C and Roche Pharma AG has announced positive results for PEGASYS combination therapy, treatment for hepatitis C.

Companies based in North America and Europe is extensively performing research and development in anti-infective antibodies segment. The major key players which are involved in production and research and development in anti-infective drugs market include Novaratis AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Gilead Sciences, Pfizer, Inc., Abbott Laboratories, Sanofi S.A., Johnson & Johnson and Bristol-Myers Squibb.

Request to View ToC of the report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=3575

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Persistence Market Research (Pmr) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.